hSIGLEC15
品系全名
C57BL/6JSmo-Siglec15tm1(hSIGLEC15)Smoc
目录号
NM-HU-190037
品系状态
胚胎冻存
基因信息
基因名
SIGLEC15
品系描述
验证数据
Fig1. SIGLEC15 人源化小鼠模型抗 SIGLEC15 人源化抗体 5G12-hIgG1 体内抗肿瘤效果 。SIGLEC15 抗体 5G12-hIgG1 能够显著抑制 MC38 肿瘤在 SIGLEC15 人源化小鼠体内的生长，证明 SIGLEC15 人源化小鼠可用于评估 anti-human SIGLEC15 antibody。（与Crownbio合作完成）
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
